AngioDynamics Shares Tumble
Back in January, AngioDynamics affirmed its outlook for fiscal 2008, predicting net sales in the range of $170-$175 million. But on Friday, the company revised […]
Back in January, AngioDynamics affirmed its outlook for fiscal 2008, predicting net sales in the range of $170-$175 million. But on Friday, the company revised […]
In February 2003, the FDA’s General and Plastic Surgery Devices Advisory Committee met and discussed thermal ablation of lung tumors. Concerns were raised about the […]
A recent study conducted by Dr. Allan Siperstein and colleagues at the Cleveland Clinic presented three and five year survival data following radiofrequency ablation of […]
A Texas jury has found that Palomar’s products do not infringe on a Candela patent. Candela had accused eight Palomar handpieces of infringing on three […]
Diomed has fought literally to the death in defense of its “777 Patent” covering the endovascular laser treatment of varicose veins. In March, the company […]
In March I reported that the market may have overreacted to AngioDynamics’ revision of its full year guidance; the company predicted full year sales in […]
A quick glance at the Diomed’s recent press releases might lead you to believe the company is a law firm, rather than a provider of […]
Copyright © 2024 | WordPress Theme by MH Themes